Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray — Membership Pricing

Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray Pricing

Pricing type	Price
TheDrugClub	Membership pricing may be available
Typical Retail	$37.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray

Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray is a prescription medication. Ask your doctor if Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray is right for you.

Other strengths and forms of Ipratropium

Combination products containing Ipratropium

Albuterol Sulfate & Ipratropium Bromide (UD

Conditions Treated with Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray

How to Check Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray Pricing

Join TheDrugClub for $19.95/month
Receive your member card by email
Present your card at a participating pharmacy
Check active-formulary eligibility or available membership pricing

Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

What Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray is approved for (FDA label)

Ipratropium bromide nasal solution, 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children age 5 years and older. Ipratropium bromide 0.06% does not relieve nasal congestion or sneezing associated with the common cold or seasonal allergic rhinitis. The safety and effectiveness of the use of ipratropium bromide 0.06% beyond four days in patients with the common cold or beyond three weeks in patients with seasonal allergic rhinitis has not been established.

Source: Read the full FDA label on DailyMed. Label effective date: July 14, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray (FDA label)

Adverse reaction information on ipratropium bromide 0.06% in patients with the common cold was derived from two multicenter, vehicle-controlled clinical trials involving 1,276 patients (195 patients on ipratropium bromide 0.03%, 352 patients on ipratropium bromide, 0.06%, 189 patients on ipratropium bromide 0.12%, 351 patients on vehicle and 189 patients receiving no treatment). Table 1 shows adverse events reported for patients who received ipratropium bromide 0.06% at the recommended dose of 84 mcg per nostril, or vehicle, administered three or four times daily, where the incidence is 1% or greater in the ipratropium bromide group and higher in the ipratropium bromide group than in the vehicle group.

Source: FDA prescribing information (DailyMed). Set ID: 7e8fdd92-1e55-47e2-aa85-e48cfebbb8d7. SPL document ID: 568fa03b-f12a-a131-e063-6294a90a66b8. Label effective date: July 14, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray (FDA label)

Ipratropium bromide nasal solution, 0.06% is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial